ENDONOVO THERAPEUTICS, INC. Retained Earnings
ENDONOVO THERAPEUTICS, INC. (ENDV) had Retained Earnings of -$66.63 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-12-29
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$66.63M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$65.86M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$67.93M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$75.12M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-09-30 | -$66.63M 10-Q · filed 2023-12-29 | |
| 2023-06-30 | -$65.86M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | -$67.93M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | -$75.12M 10-Q · filed 2023-12-29 | |
| 2022-09-30 | -$61.99M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | -$61.38M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | -$58.86M 10-Q · filed 2022-05-19 | |
| 2021-12-31 | -$56.44M 10-K · filed 2023-04-17 | |
| 2021-09-30 | -$58.84M 10-Q · filed 2021-11-19 | |
| 2021-06-30 | -$57.32M 10-Q · filed 2021-08-23 | |
| 2021-03-31 | -$56.02M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | -$53.34M 10-K · filed 2022-04-14 | |
| 2020-09-30 | -$51.31M 10-Q · filed 2020-11-19 | |
| 2020-06-30 | -$50.24M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | -$48.60M 10-Q · filed 2020-06-12 | |
| 2019-12-31 | -$52.93M 10-K · filed 2021-04-13 | |
| 2019-09-30 | -$47.27M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | -$45.86M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$38.03M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$35.62M 10-K · filed 2020-05-04 | |
| 2018-09-30 | -$37.00M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$31.05M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | -$29.80M 10-Q · filed 2018-05-18 | |
| 2017-12-31 | -$29.18M 10-K · filed 2019-04-15 | |
| 2017-09-30 | -$30.95M 10-Q/A · filed 2017-11-09 | |
| 2017-06-30 | -$24.28M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$26.14M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$18.37M 10-K · filed 2018-04-06 | |
| 2016-09-30 | -$17.63M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$15.42M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$13.96M 10-Q · filed 2016-05-27 | |
| 2015-12-31 | -$13.06M 10-K · filed 2017-04-17 | -$11.37M 10-K · filed 2016-04-05 |
| 2015-09-30 | -$8.53M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | -$7.33M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | -$6.77M 10-Q · filed 2015-06-15 | |
| 2014-12-31 | -$6.29M 10-K · filed 2016-05-17 | |
| 2013-12-31 | -$5.33M 10-K · filed 2015-06-15 | |
| 2013-09-30 | -$4.66M 10-Q · filed 2013-12-18 | |
| 2013-06-30 | -$4.21M 10-Q/A · filed 2013-08-28 | |
| 2013-03-31 | -$3.57M 10-Q/A · filed 2013-06-21 | |
| 2012-12-31 | -$2.44M 10-Q · filed 2013-12-18 | |
| 2012-09-30 | -$1.85M 10-Q · filed 2012-11-29 | |
| 2012-06-30 | -$1.46M 10-Q · filed 2012-08-20 | |
| 2012-03-31 | -$872.87K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | -$526.04K 10-K/A · filed 2013-05-03 | -$585.02K 10-K · filed 2012-04-13 |
| 2010-12-31 | -$490.93K 10-K · filed 2012-04-13 |